Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness
- PMID: 25801282
- DOI: 10.1093/hmg/ddv109
Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness
Abstract
Hearing loss is the most widespread sensory disorder, with an incidence of congenital genetic deafness of 1 in 1600 children. For many ethnic populations, the most prevalent form of genetic deafness is caused by recessive mutations in the gene gap junction protein, beta 2, 26 kDa (GJB2), which is also known as connexin 26 (Cx26). Despite this knowledge, existing treatment strategies do not completely recover speech perception. Here we used a gene delivery system to rescue hearing in a mouse model of Gjb2 deletion. Mice lacking Cx26 are characterized by profound deafness from birth and improper development of cochlear cells. Cochlear delivery of Gjb2 using an adeno-associated virus significantly improved the auditory responses and development of the cochlear structure. Using gene replacement to restore hearing in a new mouse model of Gjb2-related deafness may lead to the development of therapies for human hereditary deafness.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice.Gene Ther. 2014 Jan;21(1):71-80. doi: 10.1038/gt.2013.59. Epub 2013 Nov 14. Gene Ther. 2014. PMID: 24225640 Free PMC article.
-
BAAV mediated GJB2 gene transfer restores gap junction coupling in cochlear organotypic cultures from deaf Cx26Sox10Cre mice.PLoS One. 2011;6(8):e23279. doi: 10.1371/journal.pone.0023279. Epub 2011 Aug 18. PLoS One. 2011. PMID: 21876744 Free PMC article.
-
A deafness mechanism of digenic Cx26 (GJB2) and Cx30 (GJB6) mutations: Reduction of endocochlear potential by impairment of heterogeneous gap junctional function in the cochlear lateral wall.Neurobiol Dis. 2017 Dec;108:195-203. doi: 10.1016/j.nbd.2017.08.002. Epub 2017 Aug 17. Neurobiol Dis. 2017. PMID: 28823936 Free PMC article.
-
Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 gene.Brain Res Brain Res Rev. 2000 Apr;32(1):159-62. doi: 10.1016/s0165-0173(99)00075-2. Brain Res Brain Res Rev. 2000. PMID: 10928803 Review.
-
Gap junctions and connexins in the inner ear: their roles in homeostasis and deafness.Curr Opin Otolaryngol Head Neck Surg. 2008 Oct;16(5):452-7. doi: 10.1097/MOO.0b013e32830e20b0. Curr Opin Otolaryngol Head Neck Surg. 2008. PMID: 18797288 Review.
Cited by
-
Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges.J Clin Med. 2020 Jul 21;9(7):2309. doi: 10.3390/jcm9072309. J Clin Med. 2020. PMID: 32708116 Free PMC article. Review.
-
Potential of Gene and Cell Therapy for Inner Ear Hair Cells.Biomed Res Int. 2018 Jun 13;2018:8137614. doi: 10.1155/2018/8137614. eCollection 2018. Biomed Res Int. 2018. PMID: 30009175 Free PMC article. Review.
-
Hearing consequences in Gjb2 knock-in mice: implications for human p.V37I mutation.Aging (Albany NY). 2019 Sep 27;11(18):7416-7441. doi: 10.18632/aging.102246. Epub 2019 Sep 27. Aging (Albany NY). 2019. PMID: 31562289 Free PMC article.
-
Cochlear Health and Cochlear-implant Function.J Assoc Res Otolaryngol. 2023 Feb;24(1):5-29. doi: 10.1007/s10162-022-00882-y. Epub 2023 Jan 4. J Assoc Res Otolaryngol. 2023. PMID: 36600147 Free PMC article. Review.
-
Transduction Efficiency and Immunogenicity of Viral Vectors for Cochlear Gene Therapy: A Systematic Review of Preclinical Animal Studies.Front Cell Neurosci. 2021 Aug 30;15:728610. doi: 10.3389/fncel.2021.728610. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34526880 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
